Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418343 (US10457672, Compound 252) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418428 (US10457672, Compound 569) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.96 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM417424 (US10457672, Compound 2) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418330 (US10457672, Compound 210) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418432 (US10457672, Compound 767) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.16 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418324 (US10457672, Compound 71) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM417998 (US10457672, Compound 19) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418335 (US10457672, Compound 222) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418342 (US10457672, Compound 249) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM417391 (US10457672, Compound 1) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM417518 (US10457672, Compound 12) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418322 (US10457672, Compound 68) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM417830 (US10457672, Compound 16) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418408 (US10457672, Compound 495) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418061 (US10457672, Compound 28) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418378 (US10457672, Compound 342) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418375 (US10457672, Compound 339) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418351 (US10457672, Compound 275) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418326 (US10457672, Compound 80) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418400 (US10457672, Compound 445) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418332 (US10457672, Compound 214) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418333 (US10457672, Compound 216) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418410 (US10457672, Compound 498) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 12 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM417514 (US10457672, Compound 11) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418389 (US10457672, Compound 374) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418385 (US10457672, Compound 364) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418383 (US10457672, Compound 358) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418364 (US10457672, Compound 314) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418345 (US10457672, Compound 258) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418387 (US10457672, Compound 368) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418344 (US10457672, Compound 255) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 17 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418352 (US10457672, Compound 278) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 18 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418331 (US10457672, Compound 213) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 18 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418359 (US10457672, Compound 300) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 18 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418431 (US10457672, Compound 737) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 22 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418382 (US10457672, Compound 346) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 24 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418321 (US10457672, Compound 61) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 25 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418429 (US10457672, Compound 570) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 26 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418424 (US10457672, Compound 557) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 26 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418005 (US10457672, Compound 21) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418403 (US10457672, Compound 455) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 32 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418386 (US10457672, Compound 365) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 33 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418412 (US10457672, Compound 507) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 36 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418402 (US10457672, Compound 451) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 37 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418360 (US10457672, Compound 301) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 39 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418413 (US10457672, Compound 513) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 39 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418346 (US10457672, Compound 261) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 42 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418363 (US10457672, Compound 313) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 44 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418409 (US10457672, Compound 497) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 48 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human)) | BDBM418361 (US10457672, Compound 307) | PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of co... | US Patent US10457672 (2019) BindingDB Entry DOI: 10.7270/Q26975ZV | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 128 total ) | Next | Last >> |